Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Precision medicine in the management of type 2 diabetes
Anna L. Gloyn, Daniel J. Drucker
The Lancet Diabetes & Endocrinology (2018) Vol. 6, Iss. 11, pp. 891-900
Open Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs
Angelica Artasensi, Alessandro Pedretti, Giulio Vistoli, et al.
Molecules (2020) Vol. 25, Iss. 8, pp. 1987-1987
Open Access | Times Cited: 376
Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data
John Dennis, Beverley M. Shields, William Henley, et al.
The Lancet Diabetes & Endocrinology (2019) Vol. 7, Iss. 6, pp. 442-451
Open Access | Times Cited: 374
Diabetic kidney diseases revisited: A new perspective for a new era
Haiyan Fu, Silvia Liu, Sheldon Bastacky, et al.
Molecular Metabolism (2019) Vol. 30, pp. 250-263
Open Access | Times Cited: 181
Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations
Calvin Ke, K.M. Venkat Narayan, Juliana C.N. Chan, et al.
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 7, pp. 413-432
Open Access | Times Cited: 147
A novel diabetes typology: towards precision diabetology from pathogenesis to treatment
Christian Herder, Michael Roden
Diabetologia (2022) Vol. 65, Iss. 11, pp. 1770-1781
Open Access | Times Cited: 93
The clinical consequences of heterogeneity within and between different diabetes types
María J. Redondo, William Hagopian, Richard A. Oram, et al.
Diabetologia (2020) Vol. 63, Iss. 10, pp. 2040-2048
Open Access | Times Cited: 134
Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical Relevance
Jean Debédat, Nataliya Sokolovska, Muriel Coupaye, et al.
Diabetes Care (2018) Vol. 41, Iss. 10, pp. 2086-2095
Open Access | Times Cited: 120
Precision Medicine in Type 2 Diabetes: Using Individualized Prediction Models to Optimize Selection of Treatment
John Dennis
Diabetes (2020) Vol. 69, Iss. 10, pp. 2075-2085
Open Access | Times Cited: 83
Cluster analysis of phenotypes of patients with Behçet’s syndrome: a large cohort study from a referral center in China
Jun Zou, Jianfeng Luo, Yan Shen, et al.
Arthritis Research & Therapy (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 67
The Human Islet: Mini-Organ With Mega-Impact
John T. Walker, Diane C. Saunders, Marcela Briššová, et al.
Endocrine Reviews (2021) Vol. 42, Iss. 5, pp. 605-657
Open Access | Times Cited: 66
The neuroprotective and antidiabetic effects of trigonelline: A review of signaling pathways and molecular mechanisms
Youdan Liang, Xiaolin Dai, Yi Cao, et al.
Biochimie (2022) Vol. 206, pp. 93-104
Open Access | Times Cited: 50
Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study
Beverley M. Shields, John Dennis, Catherine Angwin, et al.
Nature Medicine (2022) Vol. 29, Iss. 2, pp. 376-383
Open Access | Times Cited: 43
Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population
Shaza B. Zaghlool, Anna Halama, Nisha Stephan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 41
The Role of Inflammation and Therapeutic Concepts in Diabetic Retinopathy—A Short Review
Krzysztof Gomułka, Michał Ruta
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1024-1024
Open Access | Times Cited: 38
Self-assembly of cascade nanoenzyme glucose oxidase encapsulated in copper benzenedicarboxylate for wearable sweat-glucose colorimetric sensors with smartphone readout
Binghua Fan, Yongjun Wu, Yongjun Wu, et al.
Analytica Chimica Acta (2024) Vol. 1316, pp. 342852-342852
Closed Access | Times Cited: 8
Mushrooms of the Genus Ganoderma Used to Treat Diabetes and Insulin Resistance
Katarzyna Wińska, Wanda Mączka, Klaudia Gabryelska, et al.
Molecules (2019) Vol. 24, Iss. 22, pp. 4075-4075
Open Access | Times Cited: 66
Genetic predisposition in type 2 diabetes: A promising approach toward a personalized management of diabetes
Mahmoud M. Sirdah, N. Scott Reading
Clinical Genetics (2020) Vol. 98, Iss. 6, pp. 525-547
Closed Access | Times Cited: 52
Precision medicine: Uses and challenges
Nardeep Naithani, Amar Tej Atal, TVSVGK Tilak, et al.
Medical Journal Armed Forces India (2021) Vol. 77, Iss. 3, pp. 258-265
Open Access | Times Cited: 41
Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models
Sandra Feijóo‐Bandín, Alana Aragón‐Herrera, Manuel Otero-Santiago, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5634-5634
Open Access | Times Cited: 34
Novel Subgroups of Type 2 Diabetes Display Different Epigenetic Patterns That Associate With Future Diabetic Complications
Silja Schrader, Alexander Perfilyev, Emma Ahlqvist, et al.
Diabetes Care (2022) Vol. 45, Iss. 7, pp. 1621-1630
Open Access | Times Cited: 30
Antidiabetic Plants for the Treatment of Type 2 Diabetes Mellitus and Associated Bacterial Infections
Mario Adrián Tienda-Vázquez, Elda M. Melchor-Martínez, Joel Horacio Elizondo-Luévano, et al.
Processes (2023) Vol. 11, Iss. 5, pp. 1299-1299
Open Access | Times Cited: 17
Plasma proteome profiling reveals the therapeutic effects of the PPAR pan-agonist chiglitazar on insulin sensitivity, lipid metabolism, and inflammation in type 2 diabetes
Xingyue Wang, You Wang, Junjie Hou, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Unveiling the future: precision pharmacovigilance in the era of personalized medicine
Lurdes Silva, Teresa Pacheco, Emília Araújo, et al.
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 3, pp. 755-760
Open Access | Times Cited: 6
Pharmacogenomic Studies of Current Antidiabetic Agents and Potential New Drug Targets for Precision Medicine of Diabetes
Zhiwei Zeng, Shiying Huang, Tao Sun
Diabetes Therapy (2020) Vol. 11, Iss. 11, pp. 2521-2538
Open Access | Times Cited: 43
CRISPR-based genome editing in primary human pancreatic islet cells
Romina J. Bevacqua, Xiao-Qing Dai, Jonathan Y. Lam, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top